Cipla’s arm to expand consumer health business: Report

30 Nov 2017 Evaluate

Cipla’s consumer healthcare arm - Cipla Health has reportedly plans to revitalize its over-the-counter (OTC) consumer business through more in-house launches and brand acquisitions in the coming quarters.

The company is looking at new product launches in segments such as gastrointestinal, pain and analgesic, cough and cold and nutritional supplements. It is also actively looking at any kind of inorganic growth through mergers and acquisitions.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. The company’s portfolio includes over 1500 products across wide range of therapeutic categories with one quality standard globally.


Cipla Share Price

1434.60 -13.00 (-0.90%)
14-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1700.55
Dr. Reddys Lab 1186.45
Cipla 1434.60
Zydus Lifesciences 884.00
Lupin 2195.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×